POMBILITI

Growth

cipaglucosidase alfa-atga

BLAINJECTIONINJECTABLE
Approved
Sep 2023
Lifecycle
Growth
Competitive Pressure
30/100

Mechanism of Action

(also known as glycogen storage disease type II, acid maltase deficiency, and glycogenosis type II) is an inherited disorder of glycogen metabolism caused by a deficiency of lysosomal acid alpha‑glucosidase (GAA) that degrades glycogen to glucose in the lysosome. GAA deficiency results in…